About the Authors
- Edward R. Samuel
-
* E-mail: edward.samuel@ucl.ac.uk
Affiliation Department of Haematology, University College London, Royal Free Campus, London, United Kingdom
- Lorea Beloki
-
Affiliation Oncohematology Research Group, Navarrabiomed-Miguel Servet Foundation, Pamplona, Spain
- Katy Newton
-
Affiliation Cell Medica Ltd, and University College London, London, United Kingdom
- Stephen Mackinnon
-
Affiliation Department of Haematology, University College London, Royal Free Campus, London, United Kingdom
- Mark W. Lowdell
-
Affiliation Department of Haematology, University College London and The Royal Free London NHS Foundation Trust, London, United Kingdom
Competing Interests
The authors have the following interests. MWL, SM and KN are shareholders in Cell Medica Ltd., a clinical-stage cellular therapeutics company, and KN is employed by Cell Medica Ltd. There are no patents, products in development or marketed products to declare. This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.
Author Contributions
Conceived and designed the experiments: ERS MWL KN. Performed the experiments: ERS LB. Analyzed the data: ERS LB MWL KN. Contributed reagents/materials/analysis tools: ERS KN. Wrote the paper: ERS MWL SM.